Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interactions among drugs for HIV and opportunistic infections.

× No keyword cloud information.

53 in total

Review 1. Drug interactions between antiretroviral drugs and comedicated agents.

Authors: Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

2. Drug Interactions Among the Antiretrovirals.

Authors: Ian R. McNicholl
Journal: Curr Infect Dis Rep Date: 2004-04 Impact factor: 3.725

3. Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration.

Authors: Julius O Soyinka; Cyprian O Onyeji; Sharon I Omoruyi; Adegbenga R Owolabi; Pullela V Sarma; James M Cook
Journal: Br J Clin Pharmacol Date: 2010-03 Impact factor: 4.335

4. Recent advances in tuberculosis: New drugs and treatment regimens.

Authors: Derek J Sloan; Geraint R Davies; Saye H Khoo
Journal: Curr Respir Med Rev Date: 2013-06-01

5. High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.

Authors: Cécile Goujard; Mayeule Legrand; Xavière Panhard; Bertrand Diquet; Xavier Duval; Gilles Peytavin; Isabelle Vincent; Christine Katlama; Catherine Leport; Bénédicte Bonnet; Dominique Salmon-Céron; France Mentré; Anne-Marie Taburet
Journal: Clin Pharmacokinet Date: 2005 Impact factor: 6.447

6. Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review.

Authors: Daniel Atwine; Maryline Bonnet; Anne-Marie Taburet
Journal: Br J Clin Pharmacol Date: 2018-05-22 Impact factor: 4.335

Interactions among drugs for HIV and opportunistic infections.

Review 1. Drug interactions between antiretroviral drugs and comedicated agents.

2. Drug Interactions Among the Antiretrovirals.

3. Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration.

4. Recent advances in tuberculosis: New drugs and treatment regimens.

5. High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.

6. Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review.

7. Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavir.

Review 8. Clinically relevant drug-drug interactions between antiretrovirals and antifungals.

Review 9. Gynecologic issues in the HIV-infected woman.

Review 10. The role of protease inhibitor therapy in children with HIV infection.